NEOG - ネオゲン （Neogen Corporation） ネオゲンNEOGのチャート
NEOGの企業情報
| symbol | NEOG |
|---|---|
| 会社名 | Neogen Corp （ネオゲン） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: In Vitro_In Vivo Diagnostic Substances |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ネオゲン(Neogen Corporation)は食品･動物安全向けの製品の開発･製造･マーケティングとサービスの提供に従事する。同社は2つの事業を運営する。食品安全事業は有害天然毒素、食物バクテリア、アレルゲンおよび一般的衛生状態を検出するために、食品製造業者およびプロセッサーが使用する診断テストキットおよび関連製品を製造、販売する。動物安全事業は獣医師と動物健康製品の販売代理店に販売される消耗品を含み、動物健康製品の製造と販売に従事する。動物安全事業はまた遺伝子同定サービスを提供する。さらに、動物安全事業は農業、食品生産およびその他の施設内・周辺のげっ歯類および病気の防除を支援するために、殺鼠剤、消毒剤および殺虫剤を製造および販売する。 ネオゲンは米国企業。食品・動物などの安全確保を目的とする製品やサ―ビスを開発、製造、販売。食品の生産者や製品加工業者に、食品および動物飼料中の危険及び不要な物質を検出するための診断検査キット、及び補完製品を提供。また、医薬品、殺鼠剤、殺菌剤、ワクチン、獣医器具、局所剤、診断製品、遺伝子検査サ―ビスを、動物安全市場向けに提供。 NEOGEN Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. NEOGEN's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants. |
| 本社所在地 | 620 Lesher Place Lansing MI 48912 USA |
| 代表者氏名 | James L. Herbert ジェームスL.ハーバート |
| 代表者役職名 | Executive Chairman of the Board 取締役会長 |
| 電話番号 | +1 517-372-9200 |
| 設立年月日 | 29738 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1989年 |
| 従業員数 | 1546人 |
| url | www.neogen.com |
| nasdaq_url | https://www.nasdaq.com/symbol/neog |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 87.58500 |
| 終値（lastsale） | 65.67 |
| 時価総額（marketcap） | 3414511650 |
| 時価総額 | 時価総額（百万ドル） 3375.941 |
| 売上高 | 売上高（百万ドル） 406.62200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3149.527 |
| 当期純利益 | 当期純利益（百万ドル） 71.26800 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 31 August 2018 Neogen Corporation revenues increased 6% to $99.6M. Net income increased 28% to $15.2M. Revenues reflect Food Safety segment increase of 13% to $52.2M. Net income benefited from Food Safety segment income increase of 24% to $10.9M. Basic Earnings per Share excluding Extraordinary Items increased from $0.23 to $0.29. |
NEOGのテクニカル分析
NEOGのニュース
Neogen to Participate in the 43rd Annual William Blair Growth Stock Conference 2023/05/30 21:00:00 PR Newswire
LANSING, Mich., May 30, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 43rd Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 6, 2023. John Adent, Neogen''s President and Chief Executive…
Neogen Corp. Launches New Assays for Natural Toxin Detection 2023/05/09 12:47:03 Investing.com
https://www.investing.com/news/assorted/neogen-corp-launches-new-assays-for-natural-toxin-detection-432SI-3077237
Neogen Launches New Assays for Natural Toxin Detection 2023/05/09 12:45:00 PR Newswire
New Reveal Q+ EndPoint assays designed for use in high-output situations LANSING, Mich., May 9, 2023 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has launched two new assays for the detection of natural toxins, Reveal Q+ for DON EndPoint and Reveal Q+ for…
Allergy Diagnostics Market Size & Share to Surpass $11841.27 Million by 2030 | Vantage Market Research 2023/04/17 11:18:41 Benzinga
WASHINGTON, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Allergy Diagnostics Market is valued at USD 5327.20 Million in 2022 and is projected to reach a value of USD 11841.27 Million by 2030 at a CAGR (Compound Annual Growth Rate) of 10.50% over the forecast period 2023-2030. Market Overview Allergy diagnostics are medical tests used to diagnose and identify allergies. They are used to determine what is causing an allergic reaction and to determine the allergies a person is suffering from. Allergy diagnostics tests measure the number of specific antibodies or proteins in the body that are associated with allergies. Common allergy diagnostics test includes skin prick tests, blood tests, and patch tests. Recent advances in technology have enabled the development of rapid, easy-to-use, and accurate allergy diagnostics tests. This has resulted in an increased demand for allergy diagnostics tests in both developed and developing countries. The Global Allergy Diagnostics Market is projected to continue to grow at a steady rate due to the increasing prevalence of allergies, rising healthcare expenditure, and the availability of innovative diagnostic techniques.
Global Veterinary Molecular Diagnostics Market Projected to Reach US$ 377.22 million by 2033, Growing at a CAGR of 6.84% | Future Market Insights, Inc. 2023/04/14 06:45:00 Accesswire
NEWARK, DE / ACCESSWIRE / April 14, 2023 / The global Veterinary Molecular Diagnostics Market is anticipated to be worth US$ 194.47 million in 2023, exceeding US$ 377.22 million by 2033. Between 2023 and 2033, the demand for veterinary molecular diagnostics is anticipated to expand at a CAGR of 6.84% . The veterinary molecular diagnostics industry is being driven by the increasing demand for animal-derived food products and the growing incidence of animal diseases. The increasing adoption of companion animals and their increasing healthcare expenditure is also contributing to the growth of the industry. In addition, the development of advanced technologies and the increasing use of molecular diagnostic tests for animal disease diagnosis is boosting the growth of the veterinary molecular diagnostics industry. The high cost of molecular diagnostics tests, the lack of skilled professionals, and the stringent regulatory framework are some of the major challenges faced by the veterinary molecular diagnostics industry.
NEOGEN Adds Synergize® Ready-to-Use Disinfectant to Biosecurity Portfolio 2022/03/01 14:28:00 PR Newswire
LEXINGTON, Ky., March 1, 2022 /PRNewswire/ -- NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a ready-to-use formulation of their Synergize® disinfectant to their biosecurity portfolio. Synergize RTU is a new formulation of the company''s Synergize disinfectant that has…
Neogen launches K-Blue Luminescent substrate 2022/02/01 20:54:10 Seeking Alpha
Neogen <> said it has added a new chemiluminescent substrate as part of the K-Blue product line.The company said K-Blue Luminescent is a two-component, luminol-based substrate…
Neogen Corp. Shares Close in on 52-Week Low - Market Mover 2022/01/16 20:34:34 Kwhen Finance
Neogen Corp. (NEOG) shares closed today at 1.8% above its 52 week low of $38.24, giving the company a market cap of $4B. The stock is currently down 14.3% year-to-date, down 6.8% over the past 12 months, and up 56.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 21.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 39.1% The company's stock price performance over the past 12 months lags the peer average by -570.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 303.8% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Jim Cramer Talks Food Testing With Neogen CEO 2022/01/05 19:08:44 The Street
Company is merging operations with 3M unit in deal long considered by Neogen, CEO tells Cramer.
Neogen launches K-Blue Luminescent substrate 2022/02/01 20:54:10 Seeking Alpha
Neogen <> said it has added a new chemiluminescent substrate as part of the K-Blue product line.The company said K-Blue Luminescent is a two-component, luminol-based substrate…
Neogen Corp. Shares Close in on 52-Week Low - Market Mover 2022/01/16 20:34:34 Kwhen Finance
Neogen Corp. (NEOG) shares closed today at 1.8% above its 52 week low of $38.24, giving the company a market cap of $4B. The stock is currently down 14.3% year-to-date, down 6.8% over the past 12 months, and up 56.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 21.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 39.1% The company's stock price performance over the past 12 months lags the peer average by -570.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 303.8% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Jim Cramer Talks Food Testing With Neogen CEO 2022/01/05 19:08:44 The Street
Company is merging operations with 3M unit in deal long considered by Neogen, CEO tells Cramer.
Neogen Corporation (NASDAQ:NEOG) earnings falls 2021/12/22 16:55:18 FXDailyReport
Neogen Corporation (NASDAQ:NEOG) stock rose 0.43% (As on Dec 22, 11:24:41 AM UTC-4, Source: Google Finance) though the company in the second quarter of FY The post Neogen Corporation (NASDAQ:NEOG) earnings falls appeared first on FXDailyReport.Com .
Neogen (NASDAQ:NEOG) Posts Quarterly Earnings Results, Misses Estimates By $0.07 EPS 2021/12/21 19:10:42 Dakota Financial News
Neogen (NASDAQ:NEOG) announced its quarterly earnings results on Tuesday. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.07), MarketWatch Earnings reports. Neogen had a net margin of 12.74% and a return on equity of 7.57%. The firm had revenue of $130.50 million during the quarter, []